-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Treatment Data for Relapsed/Refractory Multiple Myeloma and a Focus on How Multiple Myeloma Impacts African American Patients

Sponsor: Bristol Myers Squibb
Program: Product Theaters
Saturday, December 10, 2022: 11:30 AM-12:30 PM
Hall J - Theater 4 (Ernest N. Morial Convention Center)
Unicel-Anne Flores, PharmD, Bristol Myers Squibb
No relevant conflicts of interest to declare.
This presentation is intended for U.S. based registered meeting attendees

For in-person participants only

See more of: Product Theaters